# Efficacy and Safety of DWC20155/DWC20156 Combination Therapy in Patients With Gastritis

> **NCT03184415** · PHASE3 · TERMINATED · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 230 (actual)

## Conditions studied

- Gastritis

## Interventions

- **DRUG:** DWC20155
- **DRUG:** DWC20156
- **DRUG:** placebo of DWC20155
- **DRUG:** placebo of DWC20156

## Key facts

- **NCT ID:** NCT03184415
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-07-03
- **Primary completion:** 2018-05-17
- **Final completion:** 2018-05-17
- **Target enrollment:** 230 (ACTUAL)
- **Why stopped:** lack of efficacy
- **Last updated:** 2019-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03184415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03184415, "Efficacy and Safety of DWC20155/DWC20156 Combination Therapy in Patients With Gastritis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03184415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*